Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-24-005964

Options or other derivatives

  • Chief Executive Officer acquired 326,710 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2024-10-30 Grant or award · Series A-1 Convertible Preferred Shares +150 150 I: show line 1 in the form
Nijhawan Pardeep Chief Executive Officer 2024-10-30 Grant or award · Warrants (right to buy) +326,560 326,560 I: show line 2 in the form
Loading xslF345X05/ownership.xml…